title: Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src.
abstract: Angiogenesis is mediated by signaling through receptor tyrosine kinases (RTKs), Src family kinases and adhesion receptors such as integrins, yet the mechanism how these signaling pathways regulate one another remains incompletely understood. The RTK modulator, Sprouty4 (Spry4) inhibits endothelial cell functions and angiogenesis, but the mechanisms remain to be fully elucidated. In this study, we demonstrate that Spry4 regulates angiogenesis in part by regulating endothelial cell migration. Overexpression of Spry4 in human endothelial cells inhibited migration and adhesion on vitronectin (VTN), whereas knockdown of Spry4 enhanced these behaviors. These activities were shown to be c-Src-dependent and Ras-independent. Spry4 disrupted the crosstalk between vascular endothelial growth factor-2 and integrin αVβ3, the receptor for VTN. Spry4 overexpression resulted in decreased integrin β3 protein levels in a post-transcriptional manner in part by modulating its tyrosine phosphorylation by c-Src. Conversely, knockdown of Spry4 resulted in increased integrin β3 protein levels and tyrosine phosphorylation. Moreover, in vivo analysis revealed that Spry4 regulated integrin β3 levels in murine embryos and yolk sacs. Our findings identify an unanticipated role for Spry4 in regulating c-Src activity and integrin β3 protein levels, which contributes to the regulation of migration and adhesion of endothelial cells. Thus, targeting Spry4 may be exploited as a target in anti-angiogenesis therapies.
authors: Center for Molecular Medicine, Maine Medical Center Research Institute, 81 Research Drive, Scarborough, ME, 04074, USA.
authors: Yan
authors: Y
authors: Gong
authors: Xuehui
authors: X
authors: Yang
authors: Qing
authors: Q
authors: He
authors: Lindsey
authors: L
authors: Gower
authors: Igor
authors: I
authors: Prudovsky
authors: Calvin P H
authors: CP
authors: Vary
authors: Peter C
authors: PC
authors: Brooks
authors: Robert E
authors: RE
authors: Friesel
mesh_terms: D000818:Animals; D001011:Aorta / Q000166:cytology; D000081247:CSK Tyrosine-Protein Kinase; D002448:Cell Adhesion / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D004622:Embryo, Mammalian / Q000166:cytology; D042783:Endothelial Cells / Q000166:cytology* / Q000378:metabolism; D004789:Enzyme Activation; D005260:Female; D061307:Human Umbilical Vein Endothelial Cells; D006801:Humans; D039302:Integrin alphaVbeta3 / Q000502:physiology; D039661:Integrin beta3 / Q000378:metabolism* / Q000502:physiology; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D018919:Neovascularization, Physiologic / Q000502:physiology*; D009419:Nerve Tissue Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D010766:Phosphorylation; D019000:Phosphotyrosine / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D055550:Protein Stability; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012171:Retinal Vessels / Q000254:growth & development; D015854:Up-Regulation; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology; D019096:Vitronectin / Q000378:metabolism; D015017:Yolk Sac / Q000166:cytology; D019061:src-Family Kinases / Q000378:metabolism*
chemical_list: C061248:ITGB3 protein, human; D039302:Integrin alphaVbeta3; D039661:Integrin beta3; D047908:Intracellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D011993:Recombinant Fusion Proteins; C499038:SPRY4 protein, human; C499037:Spry4 protein, mouse; D019096:Vitronectin; D019000:Phosphotyrosine; D040301:Vascular Endothelial Growth Factor Receptor-2; D000081247:CSK Tyrosine-Protein Kinase; D019061:src-Family Kinases; C000631346:CSK protein, human
references: J Endocrinol. 2009 Nov;203(2):191-202
references: 19423641
references: J Biol Chem. 2001 Feb 9;276(6):4128-33
references: 11053436
references: Cell. 1994 Dec 30;79(7):1157-64
references: 7528107
references: Dev Cell. 2006 Aug;11(2):181-90
references: 16890158
references: Mol Cell. 2000 Oct;6(4):851-60
references: 11090623
references: Cell Cycle. 2003 Jul-Aug;2(4):281-2
references: 12851472
references: J Clin Invest. 1999 May;103(9):1227-30
references: 10225964
references: Nature. 2005 Dec 15;438(7070):932-6
references: 16355210
references: Nature. 1996 Apr 4;380(6573):435-9
references: 8602241
references: Circ Res. 2007 Sep 14;101(6):570-80
references: 17641225
references: Blood. 2007 Mar 1;109(5):1962-70
references: 17062734
references: PLoS One. 2011 Apr 01;6(4):e18374
references: 21483770
references: Angiogenesis. 2013 Jan;16(1):235-43
references: 23053782
references: J Cell Biol. 2001 Mar 5;152(5):1087-98
references: 11238463
references: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6041-6
references: 11983899
references: Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1703-13
references: 18658045
references: Dev Biol. 2008 Sep 1;321(1):64-76
references: 18582454
references: J Biol Chem. 2003 Aug 29;278(35):33456-64
references: 12815057
references: Calcif Tissue Int. 2006 Apr;78(4):233-40
references: 16604287
references: Curr Biol. 2003 Feb 18;13(4):308-14
references: 12593796
references: J Cell Biochem. 2007 Jan 1;100(1):151-60
references: 16888801
references: Biochem Biophys Res Commun. 2007 Jan 26;352(4):896-902
references: 17156747
references: Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L700-6
references: 12225946
references: Nat Rev Mol Cell Biol. 2009 Dec;10(12):843-53
references: 19904298
references: Angiogenesis. 2009;12(2):177-85
references: 19267251
references: J Cell Biochem. 2007 Nov 1;102(4):840-7
references: 17891779
references: Curr Opin Ophthalmol. 2007 Nov;18(6):502-8
references: 18163003
references: J Exp Med. 2006 Oct 30;203(11):2495-507
references: 17030947
references: Development. 1999 Oct;126(20):4465-75
references: 10498682
references: Dev Cell. 2010 Jul 20;19(1):148-59
references: 20643357
references: Cancer Sci. 2009 Sep;100(9):1648-54
references: 19493272
references: Surgery. 2000 Jun;127(6):696-704
references: 10840366
references: Circ Res. 2007 Mar 30;100(6):782-94
references: 17395884
references: EMBO J. 2002 Sep 16;21(18):4796-808
references: 12234920
references: Mol Cell. 1999 Dec;4(6):915-24
references: 10635317
references: J Cell Sci. 2005 Mar 15;118(Pt 6):1223-32
references: 15728256
references: Cell. 1998 Jan 23;92(2):253-63
references: 9458049
references: Science. 1994 Apr 22;264(5158):569-71
references: 7512751
references: Curr Opin Hematol. 2008 May;15(3):235-42
references: 18391791
references: Biochem J. 2005 May 1;387(Pt 3):627-37
references: 15584898
references: Nat Rev Drug Discov. 2007 Apr;6(4):273-86
references: 17396134
references: Curr Diabetes Rev. 2006 Feb;2(1):71-98
references: 18220619
references: Angiogenesis. 2008;11(1):53-62
references: 18219583
references: PLoS One. 2009;4(5):e5467
references: 19424491
references: Cell Signal. 2006 Nov;18(11):1958-66
references: 16603339
references: Mol Pharmacol. 2009 Oct;76(4):679-91
references: 19570949
references: Dev Cell. 2005 Feb;8(2):229-39
references: 15691764
references: Eur J Cancer. 1996 Dec;32A(14):2423-9
references: 9059330
references: Expert Opin Biol Ther. 2003 Apr;3(2):263-76
references: 12662141